https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34787 Wed 19 Jan 2022 15:18:05 AEDT ]]> Respiratory health effects of exposure to low-NOx unflued gas heaters in the classroom: a double-blind, cluster-randomized, crossover study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:10514 Wed 11 Apr 2018 11:31:23 AEST ]]> Treatable Traits in Elderly Asthmatics from the Australasian Severe Asthma Network: A Prospective Cohort Study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49079 Wed 03 May 2023 16:14:55 AEST ]]> Efficacy of azithromycin in severe asthma from the AMAZES randomised trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37078 Tue 29 Sep 2020 11:48:51 AEST ]]> Severe asthma: current management, targeted therapies and future directions-a roundtable report https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33751 Tue 08 Jan 2019 15:37:34 AEDT ]]> A sputum 6-gene signature predicts future exacerbations of poorly controlled asthma https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36051 Thu 28 Oct 2021 13:04:53 AEDT ]]> Severe asthma assessment, management and the organisation of care in Australia and New Zealand: expert forum roundtable meetings https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:39023 Thu 21 Apr 2022 09:51:00 AEST ]]> Sputum TNF markers are increased in neutrophilic and severe asthma and are reduced by azithromycin treatment https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49306 Thu 11 May 2023 14:32:33 AEST ]]> Long-Term Azithromycin reduces haemophilus influenzae and increases antibiotic resistance in severe asthma https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47850 Thu 02 Feb 2023 16:46:49 AEDT ]]> Asthma in older adults: a holistic, person-centred and problem-oriented approach (editorial) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:8406 Sat 24 Mar 2018 08:40:57 AEDT ]]> Asthma in older adults https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:11323 Sat 24 Mar 2018 08:12:35 AEDT ]]> Maternal asthma in Australian indigenous women and perinatal outcomes: A whole population–linked study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50309 Mon 17 Jul 2023 15:17:07 AEST ]]> Essential medicines at the national level: the global asthma network's essential asthma Medicines Survey 2014 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48275 Mon 13 Mar 2023 19:05:36 AEDT ]]> Severe asthma toolkit: an online resource for multidisciplinary health professionals–needs assessment, development process and user analytics with survey feedback https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40572 Mon 08 Aug 2022 15:11:18 AEST ]]> Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:33089 Fri 24 Aug 2018 16:46:54 AEST ]]> Clinical Phenotypes of Patients Hospitalized for an Asthma Exacerbation: Prognostic Implications https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46081 adj], 18.10 and 19.17, respectively) and mechanical ventilation (RRadj , 2.56 and 5.71, respectively) than did cluster 1. Individuals in cluster 3 had an extended length of hospital stay (11 days), increased hospitalization direct costs (13,481.57 Chinese Yuan), and a higher risk of ICU admission (RRadj , 2.14) than individuals in clusters 1 and 2. The decision tree assigned 90.8% of the participants correctly. Conclusions: We identified 3 phenotypes with differential clinical and inflammatory characteristics associated with in-hospital adverse outcomes. These new phenotypes might have important and clinically relevant implications for the management of patients hospitalized for AEs.]]> Fri 11 Nov 2022 15:15:03 AEDT ]]> The cost-effectiveness of azithromycin in reducing exacerbations in uncontrolled asthma https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46066 Fri 11 Nov 2022 14:45:17 AEDT ]]> Treatable traits can be identified in a severe asthma registry and predict future exacerbations https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37892 Fri 01 Apr 2022 09:25:28 AEDT ]]> Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36583 Fri 01 Apr 2022 09:23:30 AEDT ]]>